Early Immune System Development and Ontogeny (R01 Clinical Trial Optional)

This grant supports research to elucidate mechanisms of early immune development in utero, the early post-natal period, and early childhood, including in neonates, infants, children and adolescents with or without in-utero HIV or ART exposure. It funds studies of immune cells at the maternal-fetal interface, T- and B-cell development, maturation, local immune responses and systemic immunity.

Amount: up to $400,000
Type: Grant

Key facts

Key facts for Early Immune System Development and Ontogeny (R01 Clinical Trial Optional)
Amount	up to $400,000
Issuer	National Institutes of Health
Who can apply	Small businesses, companies, universities and 7 more
Sectors	HealthTech
Deadline	Closes 05 Nov 2028

Unlock application details

See all eligibility criteria, required documents and the official application link. Free account, no card.

Update history

Source: grants.gov ↗

Source checked yesterday

85 days agoagentImported from the official source

Opportunities with the same funding type or region
European Degree Exploratory Action		Closes 18 Feb 2027
Cooperative Agreement for affiliated Partner with Alaska Cooperative Ecosystem Studies Unit	up to $234,460	Closes 07 Dec 2026
Cooperative Agreement for affiliated Partner with Colorado Plateau Cooperative Ecosystem Studies Unit	up to $150,000	Closes 07 Dec 2026